Enfermedades Infecciosas

de Viedma, DG; Mokrousov, I; Rastogi, N.

Innovations in the molecular epidemiology of tuberculosis

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2011; 29: 8-13 Nº de citas: 49 [doi:10.1016/S0213-005X(11)70012-X]

Picazo, J; Ruiz-Contreras, J; Hernandez, B; Sanz, F; Gutierrez, A; Cercenado, E; Meseguer, MA; Delgado-Iribarren, A; Rodriguez-Avial, I; Mendez, C.

Clonal and clinical profile of Streptococcus pneumoniae serotype 19A causing pediatric invasive infections: A 2-year (2007-2009) laboratory-based surveillance in Madrid

VACCINE. 2011; 29(9): 1770-1776 Nº de citas: 19 [doi:10.1016/j.vaccine.2010.12.114]

Alonso, M; Rodriguez-Sanchez, B; Giannella, M; Catalan, P; Gayoso, J; de Quiros, JCLB; Bouza, E; de Viedma, DG.

Resistance and virulence mutations in patients with persistent infection by pandemic 2009 A/H1N1 influenza

JOURNAL OF CLINICAL VIROLOGY. 2011; 50(2): 114-118 Nº de citas: 21 [doi:10.1016/j.jcv.2010.10.007]

Mogollon, MV; Anguita, MP; Aguado, JM; Tornos, P; Miro, JM; Galvez-Acebal, J; Munoz-Sanz, A; Farinas, MD; Fernandez-Guerrero, M; Vilacosta, I; Munoz, P; Montejo-Baranda, JM; Hidalgo-Tenorio, C; Falco, V; del Rio, A; Arnaiz, AM; San-Feliu, I; de Alarcon, A.

Q fever endocarditis in Spain. Clinical characteristics and outcome

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2011; 29(2): 109-116 Nº de citas: 19 [doi:10.1016/j.eimc.2010.07.015]

Pano-Pardo, JR; Padilla, B; Romero-Gomez, MP; Moreno-Ramos, F; Rico-Nieto, A; Mora-Rillo, M; Horcajada, JP; Arribas, JR; Rodriguez-Bano, J.

Monitoring activities and improvement in the use of antibiotics in Spanish hospitals: results of a national survey

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2011; 29(1): 19-25 Nº de citas: 14 [doi:10.1016/j.eimc.2010.05.005]

Ayats, J; Martin-Mazuelos, E; Peman, J; Quindos, G; Sanchez, F; Garcia-Rodriguez, J; Guarro, J; Guinea, J; Linares, MJ; Ponton, J; Rodriguez-Tudela, JL; Cuenca-Estrella, M.

Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 update

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2011; 29(1): 39-39 Nº de citas: 22 [doi:10.1016/j.eimc.2010.08.005]

Thorne, N; Borrell, S; Evans, J; Magee, J; de Viedma, DG; Bishop, C; Gonzalez-Martin, J; Gharbia, S; Arnold, C.

IS6110-based global phylogeny of Mycobacterium tuberculosis

INFECTION GENETICS AND EVOLUTION. 2011; 11(1): 132-138 Nº de citas: 20 [doi:10.1016/j.meegid.2010.09.011]

Arendrup, M C; Meletiadis, J; Zaragoza, O; Jorgensen, K M; Marcos-Zambrano, L J; Kanioura, L; Cuenca-Estrella, M; Mouton, J W; Guinea J.

Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. ; :

ALONSO, B..

Is heparinized 40% ethanol lock solution efficient for reducing bacterial and fungal biofilms in an in vitro model?

PLoS One. ; 14: Nº de citas: 2 [doi:https://doi.org/10.1371/journal.pone.0219098]

GARCÍA DE VIEDMA, D..

Probable long-term prevalence for a predominant Mycobacterium tuberculosis clone of a Beijing genotype in Colon, Panama

Transboundary and Emerging Diseases. ; :

Alonso B; Pérez-Granda MJ; Latorre MC; Sánchez-Carrillo C; Bouza E; Muñoz P; Guembe M.

Production of biofilm by Staphylococcus aureus: Association with infective endocarditis?

Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.). ; : [doi:10.1016/j.eimc.2021.03.012]

Averbuch D; Vanbiervliet Y; Baccelli F; Mikulska M; Neofytos D; Garcia-Vidal C; Aguilar-Guisado M; Blijlevens N; Munoz P; Cordonnier C; Akova M; Calandra T.

Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in Leukaemia.

LANCET INFECTIOUS DISEASES. ; : [doi:10.1016/S1473-3099(25)00619-X]

Burillo A; Serrano-Lobo J; Bouza E; Muñoz P.

Is it possible to identify genotypes underlying resistant phenotypes in Gram-negative pathogens?

CURRENT OPINION IN INFECTIOUS DISEASES. ; : [doi:10.1097/QCO.0000000000001158]